| Literature DB >> 35369205 |
Ashlee M Hendy1, Justin W Andrushko2, Paul A Della Gatta1, Wei-Peng Teo1,3.
Abstract
Transcranial magnetic stimulation studies have demonstrated increased cortical facilitation and reduced inhibition following aerobic exercise, even when examining motor regions separate to the exercised muscle group. These changes in brain physiology following exercise may create favorable conditions for adaptive plasticity and motor learning. One candidate mechanism behind these benefits is the increase in brain-derived neurotropic factor (BDNF) observed following exercise, which can be quantified from a venous blood draw. The aim of this study was to investigate changes in motor cortex excitability and inhibition of the upper limb, and circulating BDNF, following high-intensity interval training (HIIT) on a stationary bicycle. Nineteen sedentary adults participated in a randomized crossover design study involving a single bout of high-intensity interval cycling for 20 min or seated rest. Venous blood samples were collected, and transcranial magnetic stimulation (TMS) was used to stimulate the extensor carpi radialis (ECR), where motor evoked potentials (MEP) were recorded pre- and post-condition. Following exercise, there was a significant increase (29.1%, p < 0.001) in corticospinal excitability measured at 120% of resting motor threshold (RMT) and a reduction in short-interval cortical inhibition (SICI quantified as 86.2% increase in the SICI ratio, p = 0.002). There was a non-significant (p = 0.125) 23.6% increase in BDNF levels. Collectively, these results reflect a net reduction in gamma aminobutyric acid (GABA)ergic synaptic transmission and increased glutamatergic facilitation, resulting in increased corticospinal excitability. This study supports the notion that acute high-intensity exercise provides a potent stimulus for inducing cortical neuroplasticity, which may support enhanced motor learning.Entities:
Keywords: brain-derived neurotrophic factor (BDNF); extensor carpi radialis; high-intensity interval training (HIIT); neuroplasticity; transcranial magnetic stimulation (TMS)
Year: 2022 PMID: 35369205 PMCID: PMC8967942 DOI: 10.3389/fpsyg.2022.814633
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Heart rate (HR) and rating of perceived exertion (RPE) during work periods of the high-intensity interval training (HIIT) cycling bout; bpm, beats per minute.
| HIIT | ||
|---|---|---|
| HR (bpm) | RPE | |
| 3–4 min | 141 ± 13.5 | 12.8 ± 1.7 |
| 7–8 min | 148.3 ± 12.9 | 13.8 ± 1.8 |
| 11–12 min | 152.5 ± 11.0 | 14.3 ± 1.4 |
| 15–16 min | 153.1 ± 9.1 | 14.6 ± 2.0 |
| 19–20 min | 156.1 ± 9.1 | 15.1 ± 1.7 |
Figure 1Motor evoked potential (MEP) amplitude (mV) evoked at (A) 120% resting motor threshold (RMT) and (B) 140% RMT measured PRE and POST for each participant (gray lines) with control condition shown in the left panels, and HIIT shown on the right panels. The mean amplitude for each condition is depicted by the black line. * denotes a significant condition × time interaction (p < 0.001).
Figure 2Short-interval intracortical inhibition (conditioned MEP amplitude expressed as % of unconditioned MEP120 amplitude) measured PRE and POST for each participant (gray lines) with control condition shown in the left panel, and HIIT condition shown on the right panel. The mean for each condition is depicted by the black line. * denotes a significant condition × time interaction (p = 0.002).
Blood biomarkers before and after each intervention.
| Control | HIIT | Condition × time interaction | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Change | Pre | Post | Change |
|
|
| |
| BDNF (pg/ml) | 308.7 ± 97.8 | 279.3 ± 102.5 | −9.5% | 362.1 ± 166.1 | 447.6 ± 250.2 | 23.6% | 2.811 | 0.125 | 0.219 |
| NGF (pg/L) | 387.3 ± 111.6 | 366.6 ± 91.7 | −5.3% | 326.4 ± 34.1 | 356.4 ± 110.5 | 9.2% | 1.285 | 0.283 | 0.114 |
| GDNF (pg/ml) | 28.1 ± 3.8 | 27.3 ± 2.9 | −2.8% | 26.1 ± 1.9 | 26.5 ± 3.33 | 1.5% | 0.747 | 0.408 | 0.069 |
| IGF-1 (ng/ml) | 10.6 ± 1.7 | 10.9 ± 1.5 | 2.8% | 10.3 ± 1.4 | 9.9 ± 2.2 | −3.9% | 1.155 | 0.308 | 0.104 |
| VEGF (pg/ml) | 127.1 ± 25.4 | 133.4 ± 52.0 | 5.0% | 124.2 ± 20.6 | 152.4 ± 57.4 | 22.7% | 2.726 | 0.127 | 0.199 |
indicates medium effect size (>0.13).